Transforming quantitative experimentation into biological insight


The Institute for Molecular and Cellular Biosciences (IMCB) is relaunched as the Institute for Quantitative Biosciences (IQB) on April 1st, 2018. The purpose of this new institute is to pursue cutting-edge science that explains biological processes in quantifiable terms. The reorganized IQB consists of four research clusters with clearly defined missions. The IQB will advance quantitative approaches to the life sciences, leveraging genome biology, development and neuroscience by incorporating structural biology, bioinformatics, mathematical, physical, and artificial intelligence tools. The four clusters are mutually complementary and synergistic, supported by central technology platforms and organizational provisions. The in depth quantitative investigation of dynamic biological systems will yield new solutions to benefit our society.


The Institute of Molecular and Cellular Biosciences, the IMCB, at the University of Tokyo began its history as the Institute of Applied Microbiology in 1953.  In 1993 the IMCB was reorganized and renamed to its current name to better reflect our objective of making a significant contribution to research in the entire life science disciplines.

The research at the IMCB aims at understanding life processes by elucidating the mechanisms at the cellular, molecular and organism levels.

The IMCB conducts both basic and translational research, translating our findings in basic sciences into the development of new drugs and therapies.  Our major areas of interests include drug discovery and regenerative medicine for the treatments of cancer, infectious diseases and cardiovascular diseases.